Ibuprofen & Cancer Risk: Could a Painkiller Offer Protection?
Ibuprofen, a widely used over-the-counter pain reliever for conditions like headaches, muscle aches, and menstrual pain, is now the subject of research exploring potential benefits beyond symptom relief. Scientists are investigating whether this common medication could play a role in lowering the risk of certain cancers.
How Ibuprofen Works
Ibuprofen belongs to a family of drugs called non-steroidal anti-inflammatory drugs, or NSAIDs. The link between NSAIDs and cancer prevention isn’t new; as early as 1983, the drug sulindac – similar to ibuprofen – was clinically linked to a reduced incidence of colon cancer in some patients. Researchers have since been exploring whether these drugs could help prevent or slow other cancers as well.
NSAIDs work by blocking enzymes called cyclooxygenases (COX). There are two main types: COX-1, which protects the stomach lining, maintains kidney function, and plays a role in blood clotting, and COX-2, which drives inflammation. Most NSAIDs, including ibuprofen, inhibit both, which is why doctors often recommend taking them with food.
Ibuprofen and Endometrial Cancer
A 2025 study found that ibuprofen may lower the risk of endometrial cancer, the most common type of womb cancer, which affects women mainly after menopause. Being overweight or obese is a major preventable risk factor for endometrial cancer, as excess body fat increases estrogen levels – a hormone that can stimulate cancer cell growth.
Other risk factors include older age, hormone replacement therapy (particularly estrogen-only HRT), diabetes, and polycystic ovary syndrome. Symptoms can include abnormal vaginal bleeding, pelvic pain, and discomfort during sex.
Analysis of data from more than 42,000 women aged 55–74 in the Prostate, Lung, Colorectal, and Ovarian (PLCO) study, conducted over 12 years, showed that those who reported taking at least 30 ibuprofen tablets per month had a 25% lower risk of developing endometrial cancer compared to those taking fewer than four tablets monthly. This protective effect appeared strongest among women with heart disease.
Interestingly, aspirin – another common NSAID – did not show the same association with reduced risk in this or other studies. However, aspirin may help prevent bowel cancer from returning.
Other NSAIDs, like naproxen, have been studied for preventing colon, bladder, and breast cancers, with effectiveness appearing to depend on the cancer type, genetics, and underlying health conditions.
Broader Potential and How It Works
Evidence suggests ibuprofen’s potential benefits may extend beyond endometrial cancer, with research linking its use to a lower risk of bowel, breast, lung, and prostate cancers. For example, people who previously had bowel cancer and took ibuprofen were less likely to experience recurrence.
Ibuprofen has also been shown to inhibit colon cancer growth and survival, and some evidence suggests a protective effect against lung cancer in smokers. Inflammation is a hallmark of cancer, and ibuprofen, at its core, is anti-inflammatory. By blocking COX-2 enzyme activity, the drug reduces the production of prostaglandins, chemical messengers that drive inflammation and cell growth.
Ibuprofen also appears to influence cancer-related genes – HIF-1α, NFκB, and STAT3 – which help tumor cells survive and resist treatment. It can also alter how DNA is packaged within cells, potentially making cancer cells more sensitive to chemotherapy.
Important Considerations
Research findings are not uniform. One study involving 7,751 patients found that taking aspirin after an endometrial cancer diagnosis was linked to higher mortality, particularly among those who had used aspirin before diagnosis. Other NSAIDs also appeared to increase cancer-related death risk.
Conversely, a recent review found that NSAIDs, especially aspirin, may reduce the risk of several cancers, though regular use of other NSAIDs could raise the risk of kidney cancer. These conflicting results highlight the complexity of the interaction between inflammation, immunity, and cancer.
Experts caution against self-medicating with ibuprofen for cancer prevention. Long-term or high-dose NSAID use can cause serious side effects such as stomach ulcers, gut bleeding, and kidney damage. They can also, less commonly, trigger heart problems like heart attacks or strokes, and interact with medications like warfarin and certain antidepressants.
While the idea of a common painkiller helping to prevent cancer is promising, experts agree that focusing on lifestyle-based prevention – eating anti-inflammatory foods, maintaining a healthy weight, and staying physically active – remains the most reliable approach.
Frequently Asked Questions
What is the connection between NSAIDs and cancer prevention?
The connection dates back to 1983, when clinical evidence linked sulindac, an NSAID similar to ibuprofen, to a reduced incidence of colon cancer in certain patients.
Which type of cancer showed the strongest association with ibuprofen use in the PLCO study?
The PLCO study showed a 25% lower risk of developing endometrial cancer among women who took at least 30 ibuprofen tablets per month compared to those taking fewer than four.
What are the potential risks of long-term NSAID use?
Long-term or high-dose NSAID use can cause serious side effects such as stomach ulcers, gut bleeding, and kidney damage. They can also trigger heart problems and interact with other medications.
Could further research unlock new preventative strategies using existing medications?